Corporate Board Profile
Tech Score: 25/100
1 mention(s) identify ROBERT LENK, PHD as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | 2021-04-05 | Dr. Lenk received both his PhD and BSc. from the Massachusetts Institute of Technology. We believe Dr. Lenk's broad experience in translating research candidates into products, especially in the fields of nanotechnology and liposomal drug products, brings valuable implementation skills to the Board. | Dr. Lenk has a PhD from MIT and broad experience in nanotechnology and liposomal drug products, indicating a strong technical background likely including programming skills. |
| Filing Date | Source Excerpt |
|---|---|
| 2020-05-13 | Dr. Lenk has a PhD from MIT and experience in pharmaceutical research and development, but no direct software background mentioned. |
| 2021-04-05 | Dr. Lenk received both his PhD and BSc. from the Massachusetts Institute of Technology. We believe Dr. Lenk's broad experience in translating research candidates into products, especially in the fields of nanotechnology and liposomal drug products, brings valuable implementation skills to the Board. |
| 2022-04-07 | Dr. Lenk has a PhD and experience in pharmaceuticals and nanotechnology; no mention of software engineering or programming. |
| 2023-03-07 | Dr. Lenk received his PhD and BSc from MIT and has broad experience in pharmaceuticals and nanotechnology, but no direct software programming skills are described. |
Data sourced from SEC filings. Last updated: 2026-02-03